ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

National Cancer Center Hospital East at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

National Cancer Center Hospital East takes part in 24 sessions at ESMO 2026 in Madrid. Its program focuses on precision treatment and biomarkers, particularly in digestive cancers. It examines treatment options for advanced gastric and gastroesophageal cancers, as well as how tumour DNA can inform risk and treatment decisions.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Hospital of Japan's National Cancer Center in Kashiwa, near Tokyo, focused on cancer treatment and early-phase trials.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Circulating tumor DNA (ctDNA)-informed risk prediction in breast (BC) and colorectal cancer (CRC) patients (pts): Implications for solid organ transplant (SOT)
Friday Poster Display session 1
Gastrointestinal cancersBreast cancerBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Prognostic significance of tissue factor expression and its association with coagulation-driven tumor program in gastrointestinal cancers
Friday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Validation of the ultrasensitive tumor-informed WGS MAESTRO MRD assay in β-CORRECT
Friday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Talk
Sat Oct 24
09:10–09:30
Treatment sequence and resistance mechanism to targeted therapy and immunotherapy
Optimising personalised care for gastroesophageal cancer
Gastrointestinal cancers
Abstract
Sat Oct 24
14:55–15:00
Talk
Sat Oct 24
19:30–19:45
Resistance pathways and related challenges: Options and breakthroughs in later line therapies
ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Reasoning LLMs with structured EHR data and for scalable, cross-national clinical trial eligibility screening
Sunday Poster Display session 1
Lung & thoracic cancers
Chair
Mon Oct 26
08:30–10:00
Advancing targeted and immunotherapeutic strategies in upper GI cancer
with Peking University Cancer Hospital
Gastrointestinal cancers
Poster
Mon Oct 26
12:00–12:45
Clinical and genomic landscape of de novo MET amplified NSCLC (LC-SCRUM-Asia)
Monday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Genomic scar–defined homologous recombination deficiency (HRD) and tumor immune microenvironment in endometrial cancer (EC)
Monday Poster Display session 1
Gynaecological cancersBiomarkers & precision oncology
Satellite
Mon Oct 26
13:30–13:45
Plenary: Precision oncology in focus: the evolving era in advanced GC / GEJC
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Hospital del Mar
Gastrointestinal cancers
Satellite
Mon Oct 26
13:45–13:50
Audience Q&A
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Hospital del Mar
Gastrointestinal cancers
Satellite
Mon Oct 26
13:50–14:20
Case study discussion: Current debates and developing paradigms in resectable and advanced GC / GEJC care
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Amsterdam UMC, Hospital del Mar, Geneva University Hospitals (HUG)
Gastrointestinal cancers
Satellite
Mon Oct 26
14:20–14:25
Audience Q&A
AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer · with Amsterdam UMC, Hospital del Mar, Geneva University Hospitals (HUG)
Gastrointestinal cancers
Talk
Tue Oct 27
11:20–11:40
Head and neck cancer, excl. thyroid
Scientific Congress Highlights 2

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at National Cancer Center Hospital East

Tell us what you sell and we’ll find the people at National Cancer Center Hospital East most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction